JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Eyelid Closure in Glaucoma Therapy

Not Applicable

Completed

Conditions: Glaucoma

Interventions: Other: No intervention will be assigned
Other: Eyelid closure

First Posted Date: 2009-01-30

Last Posted Date: 2012-09-20

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 60

Registration Number: NCT00832832

Locations: 🇺🇸
Johns Hopkins - The Wilmer Eye Institute, Baltimore, Maryland, United States

Trans Nasal Insufflation for the Treatment of Snoring

Completed

Conditions: Obstructive Sleep Apnea

Interventions: Device: Trans Nasal Insufflation (TNI) [nasal canula]

First Posted Date: 2009-01-29

Last Posted Date: 2023-05-12

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 11

Registration Number: NCT00832026

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Does Magnetic Resonance Imaging (MRI) Improve Interventional Outcomes for Lumbosacral Radiculopathy?

Not Applicable

Completed

Conditions: Lumbosacral Radiculopathy

Interventions: Procedure: Epidural steroid injection
Procedure: Magnetic Resonance Imaging (MRI)

First Posted Date: 2009-01-21

Last Posted Date: 2011-06-23

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 131

Registration Number: NCT00826124

Locations: 🇺🇸
Johns Hopkins School of Medicine, Baltimore, Maryland, United States
🇺🇸
Walter Reed Army Medical Center, Washington, District of Columbia, United States

Preoperative Etanercept Before Inguinal Hernia Surgery

Not Applicable

Completed

Conditions: Inguinal Hernia
Postoperative Pain

Interventions: Drug: Etanercept
Drug: Saline

First Posted Date: 2009-01-21

Last Posted Date: 2017-10-05

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 77

Registration Number: NCT00825344

Locations: 🇺🇸
Walter Reed Army Medical Center, Washington, D.C., District of Columbia, United States

Study of Daily Rifapentine for Pulmonary Tuberculosis

Phase 2

Completed

Conditions: Tuberculosis

Interventions: Drug: Rifapentine 450
Drug: Rifapentine 600
Drug: Rifampin

First Posted Date: 2008-12-25

Last Posted Date: 2018-02-06

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 153

Registration Number: NCT00814671

Locations: 🇿🇦
Universiy of Cape Town Lung Institute, Cape Town, Western Cape, South Africa

Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease

Not Applicable

Completed

Conditions: Chronic Kidney Disease

Interventions: Drug: Gardasil® Vaccine (FDA-approved vaccination regimen)

First Posted Date: 2008-12-11

Last Posted Date: 2017-07-24

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 67

Registration Number: NCT00806676

Locations: 🇺🇸
Emory Healthcare & Children's Healthcare of Atlanta Pediatric Nephrology Clinic, Atlanta, Georgia, United States
🇺🇸
Johns Hopkins University Harriet Lane Kidney Center, Rubenstein Child Health Bldg, Baltimore, Maryland, United States

Six Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly

Phase 2

Terminated

Conditions: Elderly

Interventions: Drug: GHRH

First Posted Date: 2008-12-11

Last Posted Date: 2017-04-27

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 5

Registration Number: NCT00807365

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics

Phase 4

Completed

Conditions: Psychotic Disorders

Interventions: Drug: Aripiprazole or Perphenazine
Drug: Olanzapine, quetiapine, risperidone, ziprasidone, aripiprazole, asenapine, iloperidone, lurasidone, paliperidone, or olanzapine/fluoxetine
Drug: Metformin

First Posted Date: 2008-12-10

Last Posted Date: 2017-04-25

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 127

Registration Number: NCT00806234

Locations: 🇺🇸
University of Maryland, Baltimore, Maryland, United States
🇺🇸
University of North Carolina, Division of Child and Adolescent Psychiatry, Chapel Hill, North Carolina, United States
🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

and more 1 locations

Oral 6R-BH4 for the Treatment of Isolated Systolic Hypertension and Endothelial Dysfunction

Phase 2

Terminated

Conditions: Isolated Systolic Hypertension
Endothelial Dysfunction

Interventions: Other: Placebo
Drug: 6R-BH4

First Posted Date: 2008-12-05

Last Posted Date: 2017-08-21

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 3

Registration Number: NCT00802893

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Psilocybin and Spiritual Practice

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: psilocybin
Behavioral: Intensity of support for spiritual practice
Behavioral: Number of sessions

First Posted Date: 2008-12-04

Last Posted Date: 2016-02-24

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 75

Registration Number: NCT00802282

Locations: 🇺🇸
Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy